Study: Valuentum’s Best Ideas Newsletter Portfolio
To read the study, please click on the image to download the pdf document (pdf).
AMZN
CVS Health Story Unchanged; Still Okay with Its Removal
Image Source: Mike Mozart CVS Health continues to face long-term threats to its business, and relatively weak near-term performance expectations have done little to inspire confidence. The company’s long-term debt load has exploded as it prepares to acquire Aetna, and we don’t expect the company to bounce back onto our radar given the materially increased financial leverage amidst other challenges. By Kris Rosemann Shares of former simulated newsletter portfolios idea CVS Health (CVS) continue to face pressure, and its first quarter 2018 report, released May 2, offered little support. Our opinion of the risks facing the company are unchanged, as threats such as Amazon (AMZN) teaming up with Berkshire Hathaway (BRK.A, BRK.B) and JP Morgan (JPM) to form a new healthcare company … Read more
PayPal Grows Stronger
PayPal scooped up assets that will help it better compete against Square, and we think both entities have a bright future regardless of the increased competition. Brian Nelson, CFA It’s no secret that PayPal (PYPL) generates a considerable amount of free cash flow and boasts a very strong net cash position that allows it to scoop up assets that it deems worthy of the long-term picture. Many have been concerned about PayPal’s expected loss of its contract with eBay (EBAY) in 2023, and it was quite the blow, but the entire relationship merely amounts to a few months of organic growth at the payment-processing giant. We also view Bitcoin and other cryptocurrencies as more of an opportunity than a threat for … Read more
Generic Drug Deflation Continues to Hamper Cardinal Health and AmerisourceBergen
A severe case of rampant generic drug deflation continues to hamper the share prices of Cardinal Health and AmerisourceBergen. We are monitoring the drug deflation numbers posted by the drug wholesalers as a key gauge of the investment merits of the group. By Alexander J. Poulos Key Takeaways Our interest in the drug-distribution industry centers on the group’s highly-predictive revenue model and the strong competitive positions of many underlying participants, emanating from their difficult-to-replicate distribution networks. The drug distribution industry is currently an oligopoly with McKesson, Cardinal Health and AmerisourceBergen controlling over 90% of the business. Generic drug price deflation continues to have a noticeable impact on the drug distribution industry as witnessed by the poor performance during the past … Read more
Amazon Surges; Fair Value Under Review
Amazon is no “online book store.” The company’s web services operation is a powerhouse, and its earnings potential is starting to show. We liked the company’s first-quarter 2018 results a lot. By Brian Nelson, CFA On April 26, Amazon (AMZN) reported fantastic first-quarter 2018 results after the market closed. During the period, net sales increased an incredible 43% from last year’s quarter, while operating income jumped more than 90%, to ~$1.9 billion, compared with ~$1 billion in the year-ago period. CEO Jeff Bezos continues to talk up Amazon Web Services, and the company is backing up his excitement with a surging top line and improved profitability. Operating cash flow increased 4%, to $18.2 billion, on a trailing 12-month basis, … Read more
What’s Working (or NOT Working) in Today’s Market?
Image shown: Crude oil continues to lead gainers while consumer staples, REITs, and energy MLPs continue to get shellacked. By Kris Rosemann The stock market during the first few months of 2018 has been marked by a meaningful return to volatility. Commodity prices from crude oil (USO) to aluminum have had their moments in the sun as material supply/demand imbalances of years past continue to sort themselves out, with the help of a few key players, of course (OPEC member nations in the case of crude oil, and Chinese pollution regulations and US trade policy changes in the aluminum example). Geopolitical uncertainty is keeping both world leaders and investors on their toes as the world continues to navigate multiple denuclearization … Read more
ICYMI: Valuentum’s Improved Stock and ETF Web Pages
Valuentum has rolled out improved stock and ETF web pages on its website valuentum.com/. Now, subscribers can access key proprietary information on the stock and ETF web pages in addition to the customary stock and ETF reports. Dear reader, We have some exciting news that we can’t wait to share with you! At valuentum.com/, we have rolled out new stock and ETF pages that conveniently include a variety of our proprietary metrics from the Dividend Cushion ratio to the Economic Castle rating and beyond! There’s even mouseover functionality so you can learn about how we define the key metrics across our stock-selection and dividend growth methodologies. You’ll still have access to the stock and dividend reports on the landing pages, … Read more
JD.com Set to Take on Amazon Head On
Image source: JD.com fourth quarter presentation Chinese e-commerce giant JD.com has grown at a tremendous rate in recent years, and it is expected to continue taking advantage of a ripe opportunity in its home nation. However, management has more grandiose plans for its burgeoning e-commerce platform as it expects to make its US debut before the end of 2018. By Kris Rosemann When you think of the Chinese Internet space, probably Alibaba (BABA), Tencent (TCEHY) and Baidu (BIDU) are among the first to come to mind, but there is another giant in the Chinese Internet space. You may not be aware of this, but ranked by revenue, JD.com (JD) is one of China’s largest e-commerce companies. Through its website, www.jd.com, … Read more
Walgreens Boots Alliance Remains at the Crossroads of a Rapidly-Evolving Healthcare Landscape
Image Source: Walgreens 2Q 2018 Earnings Release By Alexander J. Poulos The evolving healthcare landscape has been dealing with the threat of a disruptive new competitor entering the market and considerable political risk. Though the need for healthcare remains impervious to economic forces, a clear deflationary trend has descended on the industry that has affected many of the well-entrenched participants. Let’s examine Walgreens Boots Alliance for clues that a shift in sentiment may have occurred in this well known, yet beleaguered sector. We’re watching Walgreen’s equity very closely. The Consolidation Trend Continues One of the often overlooked, but in our view, key dynamics affecting the drug distributers/retailers such as Walgreens Boots Alliance (WBA) is the continued deflationary trends exhibited in … Read more
Trump Knocks Air Out of Amazon; Intel Investors Overreact to Apple News
Only fools, or worse, are saying that our money losing Post Office makes money with Amazon. THEY LOSE A FORTUNE, and this will be changed. Also, our fully tax paying retailers are closing stores all over the country…not a level playing field! — Donald J. Trump (@realDonaldTrump) April 2, 2018 President Trump continues to move markets, and his messages about Amazon haven’t gone unnoticed. Apple seems to be targeting wider gross margins in coming years, as it looks to bring in-house a part of its supply chain. Intel’s shares overreact. By Brian Nelson, CFA President Trump seems to want to put Amazon (AMZN) in its place, and his recent comments have been a source of fear for many investors of … Read more